Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-11-24 Purchase | 2020-11-25 5:01 pm | Stoke Therapeutics Inc. | STOK | Apple Tree Partners IV L.P. ATP III GP Ltd. 10% Owner | 375,000 | $39 | $14,625,000 | 17,161,713 (Direct) | View |
| 2020-07-10 Purchase | 2020-07-14 4:46 pm | Akero Therapeutics Inc. | AKRO | Apple Tree Partners IV L.P. ATP III GP Ltd. 10% Owner | 415,000 | $36 | $14,940,000 | 5,830,203 (Direct) | View |
| 2019-06-24 Purchase | 2019-06-25 6:04 pm | Akero Therapeutics Inc. | AKRO | Apple Tree Partners IV L.P. ATP III GP Ltd. 10% Owner | 900,000 | $16 | $14,400,000 | 5,415,203 (Direct) | View |
| 2019-06-21 Purchase | 2019-06-21 4:59 pm | Stoke Therapeutics Inc. | STOK | Apple Tree Partners IV L.P. ATP III GP Ltd. 10% Owner | 1,388,889 | $18 | $25,000,002 | 16,786,713 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-06-28 Other | 2021-06-30 4:32 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | ATP Life Science Ventures L.P. ATP III GP Ltd. 10% Owner | 17,161,713 | $0 | 17,161,713 (Direct) | View |
| 2021-06-28 Other | 2021-06-30 4:31 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | ATP Life Science Ventures L.P. ATP III GP Ltd. 10% Owner | 5,830,203 | $0 | 5,830,203 (Direct) | View |
| 2019-06-24 Conversion | 2019-06-25 6:04 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Apple Tree Partners IV L.P. ATP III GP Ltd. 10% Owner | 18,395,771 | $0 | 5,415,203 (Direct) | View |
| 2019-06-21 Conversion | 2019-06-21 4:59 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Apple Tree Partners IV L.P. ATP III GP Ltd. 10% Owner | 15,397,824 | $0 | 16,786,713 (Direct) | View |
Ownership | 2019-06-19 6:30 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Apple Tree Partners IV L.P. ATP III GP Ltd. Harrison Seth Loring 10% Owner | 0 | $0 | 4,515,203 (Indirect) | View |
Ownership | 2019-06-18 8:49 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Apple Tree Partners IV L.P. ATP III GP Ltd. 10% Owner | 0 | $0 | 15,397,824 (Direct) | View |